Fludeoxyglucose F18
Fludeoxyglucose F18 is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Fludeoxyglucose F18; Generic name: FLUDEOXYGLUCOSE F18; Drug class: Radioactive Diagnostic Agent [EPC].
| Brand name | Fludeoxyglucose F18 |
|---|---|
| Generic name | FLUDEOXYGLUCOSE F18 |
| Drug class | Radioactive Diagnostic Agent [EPC] |
| Manufacturer | MIPS Cyclotron & Radiochemistry Facility |
| Used for | 1 INDICATIONS AND USAGE Fludeoxyglucose F18 Injection is indicated for positron emission tomography (PET) imaging in the following settings: Fludeoxyglucose F18 Injection is indicated for positron emission tomography (PET) imaging in the following settings: Oncology: For assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. Cardiology: For the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysf |
| Dosage | 2 DOSAGE AND ADMINISTRATION Fludeoxyglucose F18 Injection emits radiation. Use procedures to minimize radiation exposure. Calculate the final dose from the end of synthesis (EOS) time using proper radioactive decay factors. Assay the final dose in a properly calibrated dose calibrator before administration to the patient [ see Description (11.2) ]. Fludeoxyglucose F18 Injection emits radiation. Use procedures to minimize radiation exposure. Screen for blood glucose abnormalities. In the oncology |
| Active ingredient(s) | FLUDEOXYGLUCOSE F-18 |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ec2d4d1-b295-18dc-e054-00144ff88e88 |